The global healthcare community faces a continuous challenge in treating substance use disorders and long-term chemical dependencies. Traditional pharmaceutical interventions often focus on substitution therapies, which can prolong a patient’s dependence on exogenous substances. This ongoing struggle has led clinical researchers to explore unconventional ethnobotanical options. Among these, ibogaine—a naturally occurring indole alkaloid extracted from […]
The search for therapeutic agents capable of altering entrenched neuropsychiatric patterns has led modern science to evaluate complex ethnobotanical compounds. Among these, ibogaine stands out as a unique indole alkaloid that breaks traditional pharmaceutical classifications. Extracted primarily from the root bark of the central African shrub Tabernanthe iboga, this molecule has transitioned from its ancestral, […]